Basir Eye health Research Center
  • Register
  • Login

Journal of Ophthalmic and Optometric Sciences

  • Home
  • About
    • About the Journal
    • Editorial Policies
    • Indexing & Abstracting
    • Privacy Statement
  • Current Issue
  • Archives
  • Editorial Team
  • Ethical Considerations
  • Copy Right Form
  • Author Guidelines
  • Submit Article
  • COPE Compliance
  • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 3 No. 1 (2019): Winter
  4. Original Articles

Vol. 3 No. 1 (2019)

January 2019

The Long Term Outcome of Ahmed Glaucoma Valve Insertion in Neovascular Glaucoma

  • Maryam Yadgari
  • Kiana Hassanpour

Journal of Ophthalmic and Optometric Sciences, Vol. 3 No. 1 (2019), 1 January 2019 , Page 1-5
https://doi.org/10.22037/joos.v3i1.30623 Published: 2019-01-01

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Purpose: To evaluate the efficacy of Ahmed glaucoma valve (AGV) implantation for neovascular glaucoma (NVG), in short, intermediate, and long term follow ups.

Patients and Methods: The present study was a retrospective review of 23 eyes of 23 patients with NGV who underwent AGV implantation at Imam Hussein Medical Center, Tehran, Iran, between January 2008 and March 2017. Pre and post operative intraocular pressure (IOP), visual acuity, surgical success rate, number of medications, and complications were recorded. The primary outcome was surgical success  defined  in  terms  of  5 ≤ IOP ≤ 21 mmHg and at least 20 %  reduction  in  IOP without glaucoma medication (complete success), or with medications (qualified success). The sum of complete success and qualified success was reported as cumulative success.

Results: The mean follow up period was 4.69 years (range, 2-10 years). The mean IOP was significantly lower compared to preoperative mean at each postoperative visit up to three years (P < 0.001). The cumulative surgical success rate at 1 year, 2 years and 3 years were 91.3 %, 82.6 %, 78.3 % respectively. The mean number of drugs needed to control IOP was significantly lower compared to preoperative mean at each postoperative visit up to three years.

 

Keywords:
  • Glaucoma Neovascular Treatment Outcome Iran
  • PDF

How to Cite

Yadgari, M., & Hassanpour, K. (2019). The Long Term Outcome of Ahmed Glaucoma Valve Insertion in Neovascular Glaucoma. Journal of Ophthalmic and Optometric Sciences, 3(1), 1–5. https://doi.org/10.22037/joos.v3i1.30623
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007;26(5):470‐85.

Olmos LC, Lee RK. Medical and surgical treatment of neovascular glaucoma. Int Ophthalmol Clin. 2011;51(3):27‐36.

Stevens GA, White RA, Flaxman SR, Price H, Jonas JB, Keeffe J, et al. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology. 2013;120(12):2377‐84.

Vinod K, Gedde SJ, Feuer WJ, Panarelli JF, Chang TC, Chen PP, et al. Practice Preferences for Glaucoma Surgery: A Survey of the American Glaucoma Society. J Glaucoma. 2017;26(8):687‐93.

Rodrigues GB, Abe RY, Zangalli C, Sodre SL, Donini FA, Costa DC, et al. Neovascular glaucoma: a review. Int J Retina Vitreous. 2016;2:26.

Allen RC, Bellows AR, Hutchinson BT, Murphy SD. Filtration surgery in the treatment of neovascular glaucoma. Ophthalmology. 1982;89(10):1181‐7.

Mietz H, Raschka B, Krieglstein GK. Risk factors for failures of trabeculectomies performed without antimetabolites. Br J Ophthalmol. 1999;83(7):814‐21.

Katz GJ, Higginbotham EJ, Lichter PR, Skuta GL, Musch DC, Bergstrom TJ, et al. Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. Ophthalmology. 1995;102(9):1263‐9.

Hyung SM, Kim SK. Mid-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients. Korean J Ophthalmol. 2001;15(2):98‐106.

HaiBo T, Xin K, ShiHeng L, Lin L. Comparison of Ahmed glaucoma valve implantation and trabeculectomy for glaucoma: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0118142.

Yap-Veloso MI, Simmons RB, Echelman DA, Gonzales TK, Veira WJ, Simmons RJ. Intraocular pressure control after contact transscleral diode cyclophotocoagulation in eyes with intractable glaucoma. J Glaucoma. 1998;7(5):319‐28.

Shen SY, Lai JS, Lam DS. Necrotizing scleritis following diode laser transscleral cyclophotocoagulation. Ophthalmic Surg Lasers Imaging. 2004;35(3):251‐3.

Delgado MF, Dickens CJ, Iwach AG, Novack GD, Nychka DS, Wong PC, et al. Long-term results of noncontact neodymium:yttrium-aluminum-garnet cyclophotocoagulation in neovascular glaucoma. Ophthalmology. 2003;110(5):895‐9.

Yalvac IS, Eksioglu U, Satana B, Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye (Lond). 2007;21(1):65‐70.

Netland PA, Ishida K, Boyle JW. The Ahmed Glaucoma Valve in patients with and without neovascular glaucoma. J Glaucoma. 2010;19(9):581‐6.

Shen CC, Salim S, Du H, Netland PA. Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma. Clin Ophthalmol. 2011;5:281‐6.

  • Abstract Viewed: 246 times
  • PDF Downloaded: 105 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact
Powered by OJSPlus